[1] Miguel A,Azevedo LF,Araújo M,et al.Frequency of adverse drug reactions in hospitalized patients:a systematic review and Meta-analysis. Pharmacoepidemiol Drug Saf,2012,21(11):1139-1154. [2] Fisher K,Vuppalanchi R,Saxena R.Drug-induced liver injury. Arch Pathol Lab Med,2015,139(7):876-887. [3] Zhou Y,Yang L,Liao Z,et al.Epidemiology of drug-induced liver injury in China:a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol,2013,25(7):825-829. [4] Danan G,Benichou C.Causality assessment of adverse reactions to drugs-i. a novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries. J Clin Epidemiol,1993,6(11):1323-1330. [5] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16(3):210-216. [6] Chalasani NP,Hayashi PH,Bonkovsky HL,et al.Acg clinical guideline:the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol,2014,109(7):950-966. [7] Hayashi PH,Fontana RJ.Clinical features,diagnosis,and natural history of drug-induced liver injury. Semin Liver Dis,2014,34(2):134-144. [8] Robles-Diaz M,Lucena MI,Kaplowitz N,et al.Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology,2014,147(1):109-118. [9] 张岱,王炳元. 重视损肝药物的新成员. 实用肝脏病杂志,2017,20(2):129-133. [10] 施慧,魏娟,王震凯,等. 住院患者药物性肝损伤病因分析及熊去氧胆酸协同治疗疗效观察. 实用肝脏病杂志,2015,18(1):34-37. [11] 邓鸣,李敬来,张振清.性别对药动学和药效学影响的研究进展. 中国药学杂志,2013,48(9):667-671. [12] Chikhani M,Hardman JG.Pharmacokinetic variation. Anaesth Intens Care Med,2011,12(8):368-370. [13] Lucena MI,Andrade RJ,Kaplowitz N,et al.Phenotypic characterization of idiosyncratic drug-induced liver injury:the influence of age and sex. Hepatology,2009,49(6):2001-2009. [14] 陆玮婷,李军. 276例药物性肝损伤的病因和临床表现分析.中华肝脏病杂志,2006,14(11):832-834. [15] 李平,谢同柄. 132例药物性肝损伤临床分析. 实用肝脏病杂志,2010,13(1):48-50. [16] McGill MR,Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure:from preclinical models to patients. Expert Opin Drug Metab Toxicol,2014,10(7):1005-1017. [17] Elinav E,Pinsker G,Safadi R,et al.Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol,2007,47(4):514-520. [18] Devarbhavi H,Dierkhising R,Kremers WK,et al.Single-center experience with drug-induced liver injury from India:causes,outcome,prognosis,and predictors of mortality. Am J Gastroenterol,2010,105(11):2396-2404. [19] Zimmerman HJ.Drug-induced liver disease. Clin Liver Dis,2000,4(1):73-96. [20] Willy ME,Li Z.What is prescription labeling communicating to doctors about hepatotoxic drugs A study of FDA approved product labeling. Pharmacoepidemiol Drug Saf,2004,13(4):201-206. |